Clinical Trials in Arizona

Showing 9501-9520 of 14,395 trials

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

NCT03039634

This study evaluates the safety, effectiveness, and maintenance of effect of a novel topical silver particle solution (Sienna 755.1100, 810.1100, or 1064.1100) used in conjunction with a laser for the treatment of Acne Vulgaris.

Acne Vulgaris

Sienna Labs76 participantsStarted Aug 2016

Scottsdale, Arizona, United States • Santa Monica, California, United States • Coral Gables, Florida, United States +13 more locations

TERMINATEDPhase 331 miles

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

NCT01785771

An 39-week plus extensions, open-label study to estimate the reduction in HbA1c in patients with initial HbA1c \>10% \</=12% who are treated with ITCA 650 20 mcg/day for 13 weeks followed by ITCA 650 60 mcg/day for 26 weeks plus optional 26-week extensions with continued treatment with ITCA 650 60 mcg/day

Type 2 Diabetes

Intarcia Therapeutics100 participantsStarted May 2013

Birmingham, Alabama, United States • Gulf Shores, Alabama, United States • Chandler, Arizona, United States +48 more locations

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Find Trials by Condition in Arizona

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Inflammation and the Host Response to Injury (Trauma)

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors